COMMUNIQUÉS West-GlobeNewswire

RedHill Biopharma Announces Pricing of $20 Million Underwritten Offering

06/12/2018 - 14:44

TEL-AVIV, Israel and RALEIGH, N.C., Dec. 06, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq:RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily [...]

Oncology Ventures CEO Peter Buhl Jensen buys shares in the Company

06/12/2018 - 14:36

Company Announcement Oncology Ventures CEO Peter Buhl Jensen buys shares in the Company Hoersholm, Denmark – December 6, 2018 – Oncology Venture A/S (OV:ST) announces that CEO Peter Buhl Jensen, through Buhl Krone [...]

Olainfarm holds Third Quarter 2018 Investor Conference Webinar

06/12/2018 - 14:34

JSC Olainfarm invites shareholders, investors, mass media representatives and other stakeholders to join its investor conference webinar scheduled today, on December 6, 2018 at 16:00 (EEST). To join the webinar please [...]

Marrone Bio Innovations Launches TerraConnect™ New Biological Seed and Soil Platform

06/12/2018 - 14:31

DAVIS, Calif., Dec. 06, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), launches TerraConnect, a new global biological soil applied and seed treatment platform delivering growers high [...]

VPR Brands Letter to Shareholders 2018

06/12/2018 - 14:30

Fort Lauderdale, FL, Dec. 06, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – VPR Brands, LP (OTC Pink: VPRB): December 6, 2018 Dear Valued Shareholders, As we enter the holiday season, I wanted to take this opportunity to [...]

NexTech Looks to Bring Augmented Reality to Ecommerce-- CFN Media

06/12/2018 - 14:30

SEATTLE, Dec. 06, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]

SELLAS Life Sciences Announces Additional Positive Triple Negative Breast Cancer (TNBC) Subgroup Data from Phase 2b Study of Nelipepimut-S Plus Trastuzumab at the 2018 San Antonio Breast Cancer Symposium

06/12/2018 - 14:30

Clinically Meaningful and Statistically Significant Decrease in the Frequency of Clinically Detected Recurrences in the TNBC Cohort Treated with Nelipepimut-S plus Trastuzumab (p=0.004) Specific Benefit in Four [...]

Ultragenyx and Kyowa Kirin Announce Health Canada Approval of Crysvita™ (burosumab injection) for the Treatment of X–linked Hypophosphatemia (XLH) in Adults and Children

06/12/2018 - 14:30

First Approved Treatment for XLH in Canada that Targets the Underlying Cause of this Rare, Hereditary, Lifelong Disease NOVATO, Calif., TOKYO and LONDON, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc [...]

BriaCell Presents Positive Efficacy Data with Lead Cancer Drug Candidate in Phase IIa Monotherapy and Excellent Initial Safety Data in Combination with KEYTRUDA® at a Major Breast Cancer Conference

06/12/2018 - 14:30

Interim data indicate an excellent safety profile for the combination regimen in advanced breast cancer patients. Initial efficacy data is expected in first quarter of 2019; Confirmed positive proof-of-concept with Bria [...]

Myriad Validates Polygenic Score to Predict Breast Cancer Risk in Women of Hispanic Ancestry Who Test Negative for Hereditary Cancer Mutations

06/12/2018 - 14:30

SALT LAKE CITY, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics , Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and personalized medicine, today announced results from an important study to validate the [...]

First Choice Healthcare Solutions Governance Appointments

06/12/2018 - 14:30

The Independent Board of Directors Announce Additional Updates Melbourne, Fla., Dec. 06, 2018 (GLOBE NEWSWIRE) -- First Choice Healthcare Solutions, Inc. (OTCQB: FCHS) ("First Choice" or the "Company"), a physician [...]

Organovo Appoints New Board Member

06/12/2018 - 14:05

SAN DIEGO, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pioneering the development of 3D bioprinted tissues aimed at treating a range of serious adult and [...]

Immunomedics Provides Clinical Updates on Breast Cancer Programs With Sacituzumab Govitecan

06/12/2018 - 14:03

Updated Phase 2 Results in Metastatic Triple-Negative Breast Cancer to be Presented at The 2018 San Antonio Breast Cancer Symposium (SABCS) Continue to Show Meaningful Clinical Benefit Consistent with Prior Results [...]

Nuvectra Completes 3,000 U.S. Algovita® SCS Implantations

06/12/2018 - 14:01

PLANO, Texas, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that the Company’s Algovita ® Spinal Cord Stimulation (SCS) system has been [...]

Ovid Therapeutics Announces Plans to Move into a Phase 3 Trial in Pediatric Patients Based on End-of-Phase 2 Meeting for OV101 in Angelman Syndrome

06/12/2018 - 14:01

-- Single pivotal Phase 3 trial design, using once-daily dosing, may be sufficient for approval of OV101 in Angelman syndrome -- -- Trial initiation activities have begun for ELARA, an open-label extension study for [...]

Rhythm Pharmaceuticals to Host Key Opinion Leader Symposium on MC4R Pathway and Patient Experience with Rare Genetic Disorders of Obesity, Including Bardet-Biedl Syndrome

06/12/2018 - 14:00

BOSTON, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a biopharmaceutical company focused on the development and commercialization of therapeutics for the treatment of rare genetic [...]

Avinger Announces Commercial Launch in Australia

06/12/2018 - 14:00

Pantheris Receives Regulatory Clearance and First Patients Treated Successfully with Pantheris in Australia REDWOOD CITY, Calif., Dec. 06, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical [...]

BioSig Technologies To Commence First–in-Human Studies at Mayo Clinic

06/12/2018 - 14:00

Leading Institution to Become the Second Center after TCAI to Launch the Studies with PURE EP System Santa Monica, CA, Dec. 06, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company [...]

Chembio’s French Partner AAZ-LMB Wins Prix Galien International for Best Medical Technology with autotest VIH®

06/12/2018 - 14:00

MEDFORD, N.Y., Dec. 06, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced that its French HIV self-test [...]